Abstract
Severe protein C deficiency due to biallelic PROC mutations is an extremely rare thrombophilia, most commonly presenting during the neonatal period as purpura fulminans. Despite treatment, severe morbidity and mortality are frequent. The current study reports 3 unrelated patients harboring novel homozygous PROC mutations and their clinical phenotypes. We discuss how the cytoprotective activity of protein C and its role in the stabilization of endothelial barriers may account for the unique symptoms of this thrombophilia.
References
1.
Van Der Horst
RL
. Purpura fulminans in a newborn baby
. Arch Dis Child
. 1962
Aug
;37
(194
):436
–41
.
[PubMed]
0003-98882.
Marciniak
E
, Wilson
HD
, Marlar
RA
. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood
. Blood
. 1985
Jan
;65
(1
):15
–20
.
[PubMed]
0006-49713.
Esmon
CT
. Molecular events that control the protein C anticoagulant pathway
. Thromb Haemost
. 1993
Jul
;70
(1
):29
–35
.
[PubMed]
0340-62454.
Bouwens
EA
, Stavenuiter
F
, Mosnier
LO
. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway
. J Thromb Haemost
. 2013
Jun
;11
Suppl 1
:242
–53
.
[PubMed]
1538-79335.
D’Ursi
P
, Marino
F
, Caprera
A
, Milanesi
L
, Faioni
EM
, Rovida
E
. ProCMD: A database and 3D web resource for protein C mutants. BMC Bioinform. 2007
8;8 Suppl 1:S11.6.
Goldenberg
NA
, Manco-Johnson
MJ
. Protein C deficiency
. Haemophilia
. 2008
Nov
;14
(6
):1214
–21
.
[PubMed]
1351-82167.
Monagle
P
, Chan
AK
, Goldenberg
NA
, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis
, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012
;141(suppl 2):e737S–e801S. 8.
Limperger
V
, Klostermeier
UC
, Kenet
G
, Holzhauer
S
, Alhenc Gelas
M
, Finckh
U
, et al. Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study
. Br J Haematol
. 2014
Nov
;167
(3
):385
–93
.
[PubMed]
0007-10489.
Spector
EB
, Grody
WW
, Matteson
CJ
, Palomaki
GE
, Bellissimo
DB
, Wolff
DJ
, et al. Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G [{GT}]A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories
. Genet Med
. 2005
Jul-Aug
;7
(6
):444
–53
.
[PubMed]
1098-360010.
Martos
L
, Fernández-Pardo
Á
, López-Fernández
MF
, Ibáñez
F
, Herrero
S
, Tàssies
D
, et al.; Working Group of the Spanish Society of Thrombosis Haemostasis (SETH)
. Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency
. Thromb Haemost
. 2019
Sep
;119
(9
):1409
–18
.
[PubMed]
0340-624511.
Inoue
H
, Terachi
SI
, Uchiumi
T
, Sato
T
, Urata
M
, Ishimura
M
, et al. The clinical presentation and genotype of protein C deficiency with double mutations of the protein C gene
. Pediatr Blood Cancer
. 2017
Jul
;64
(7
):e26404
.
[PubMed]
1545-500912.
Zhao
R
, Lin
H
, Bereza-Malcolm
L
, Clarke
E
, Jackson
CJ
, Xue
M
. Activated Protein C in Cutaneous Wound Healing: From Bench to Bedside. Int J Mol Sci 2019
;19;20(4).13.
Dreyfus
M
, Masterson
M
, David
M
, Rivard
GE
, Müller
FM
, Kreuz
W
, et al. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency
. Semin Thromb Hemost
. 1995
;21
(4
):371
–81
.
[PubMed]
0094-617614.
Pulido
JS
, Lingua
RW
, Cristol
S
, Byrne
SF
. Protein C deficiency associated with vitreous hemorrhage in a neonate
. Am J Ophthalmol
. 1987
Nov
;104
(5
):546
–7
.
[PubMed]
0002-939415.
Cassels-Brown
A
, Minford
AM
, Chatfield
SL
, Bradbury
JA
. Ophthalmic manifestations of neonatal protein C deficiency
. Br J Ophthalmol
. 1994
Jun
;78
(6
):486
–7
.
[PubMed]
0007-116116.
Douglas
AG
, Rafferty
H
, Hodgkins
P
, Nagra
A
, Foulds
NC
, Morgan
M
, et al. Persistent Fetal Vasculature and Severe Protein C Deficiency
. Mol Syndromol
. 2010
;1
(2
):82
–6
.
[PubMed]
1661-876917.
Kirkegaard
K
, Heegaard
S
, Hvas
AM
. No evidence for thrombophilia in patients with retinal venous occlusion: a systematic GRADE-based review
. Acta Ophthalmol
. 2017
Feb
;95
(1
):12
–9
.
[PubMed]
1755-375X18.
Manco-Johnson
MJ
, Bomgaars
L
, Palascak
J
, Shapiro
A
, Geil
J
, Fritsch
S
, et al. Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency
. Thromb Haemost
. 2016
Jul
;116
(1
):58
–68
.
[PubMed]
0340-624519.
Rosenzweig
N
, Strauss
T
, Rubinstein
M
, Paret
G
, Kenet
G
. Activated protein C concentrate treatment for skin necrosis under warfarin treatment in severe genetic protein C deficiency combined with prothrombin mutation and factor V Leiden
. Thromb Haemost
. 2009
Feb
;101
(2
):405
–7
.
[PubMed]
0340-624520.
Rosendaal
FR
, Koster
T
, Vandenbroucke
JP
, Reitsma
PH
. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
. Blood
. 1995
Mar
;85
(6
):1504
–8
.
[PubMed]
0006-497121.
Koeleman
BP
, Reitsma
PH
, Allaart
CF
, Bertina
RM
. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
. Blood
. 1994
Aug
;84
(4
):1031
–5
.
[PubMed]
0006-497122.
Hallam
PJ
, Millar
DS
, Krawczak
M
, Kakkar
VV
, Cooper
DN
. Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency
. J Med Genet
. 1995
Jul
;32
(7
):543
–5
.
[PubMed]
0022-259323.
Perrin
GQ
, Herzog
RW
, Markusic
DM
. Update on clinical gene therapy for hemophilia
. Blood
. 2019
Jan
;133
(5
):407
–14
.
[PubMed]
0006-497124.
Zabaleta
N
, Hommel
M
, Salas
D
, Gonzalez-Aseguinolaza
G
. Genetic based approaches to inherited metabolic liver diseases
. Hum Gene Ther
. 2019
Oct
;30
(10
):1190
–203
.
[PubMed]
1043-034225.
Cai
SR
, Kennedy
SC
, Bowling
WM
, Flye
MW
, Ponder
KP
. Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy
. J Clin Invest
. 1998
Jun
;101
(12
):2831
–41
.
[PubMed]
0021-9738© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.